Page last updated: 2024-09-05

cirsimaritin and Diabetes Mellitus, Type 2

cirsimaritin has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ1
AbuDalo, R; Al-Hashimi, N; Alqudah, A; Alqudah, M; Alshaikh, HA; Athamneh, RY; Gammoh, O; Oqal, M; Qnais, E1

Reviews

1 review(s) available for cirsimaritin and Diabetes Mellitus, Type 2

ArticleYear
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship

2018

Other Studies

1 other study(ies) available for cirsimaritin and Diabetes Mellitus, Type 2

ArticleYear
The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment.
    International journal of molecular sciences, 2023, Mar-17, Volume: 24, Issue:6

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Metformin; Rats; Streptozocin

2023